Groowe BETA / Newsroom

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

businesswire.com August 3, 2026 at 3:30 PM ET

ARWR The article reports on inducement grants made by Arrowhead Pharmaceuticals under a NASDAQ listing rule. This is a routine administrative disclosure and does not inherently reflect the company's performance or future prospects.